FDA Issues Draft Guidance to Accelerate Cell and Gene Therapies for Patients
FDA draft guidance proposes leveraging existing platform knowledge to streamline development of cell and gene therapies for rare and life-threatening diseases.
InstitutionsETF Recommends Updating COVID-19 Vaccines to Target XFG Variant
EMA's Emergency Task Force recommends updating COVID-19 vaccines to target the XFG variant for the 2026/2027 vaccination campaign.
InstitutionsFDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
FDA draft guidance aims to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs, potentially accelerating timelines for human trials.
InstitutionsEU recommendations for 2026/2027 seasonal flu vaccine composition
Annual updates to virus strains ensure vaccines stay effective
InstitutionsEMA Recommends First Oral GLP-1 Treatment for Weight Management
EMA recommends first oral GLP-1 (semaglutide) for weight management, offering Wegovy tablets as an alternative to injections.
InstitutionsLab Lexicon Now Available in German
Lab Lexicon adds German as its seventh language, making laboratory science more accessible to German-speaking scientists worldwide.
MetaFDA Finalizes Food Chemical Safety Program, Launches Reassessment of BHT and ADA
FDA finalized its post-market assessment program for food chemicals and launched reassessments of BHT and ADA.
InstitutionsFDA Advances Drug Repurposing to Address Unmet Medical Needs
FDA is soliciting public input on drug repurposing to accelerate treatments for chronic and rare diseases.
InstitutionsLab Lexicon Now Available in French, Portuguese, and Indonesian
Lab Lexicon expands its reach with the addition of French, Brazilian Portuguese, and Indonesian language support, making laboratory science more accessible worldwide.
MetaNew Safety Standard for Mexican University Labs
New safety standard for Mexican university labs
PublicationsFDA Intensifies Efforts to Import Lower-Cost Drugs
FDA Intensifies Efforts with States to Import Lower-Cost Canadian Drugs.
InstitutionsShowing 25 to 35 of 35 results